Report this article
Use this form to bring a problem with Observations on an Open‐Label Phase 1/2 Dopamine Gene Therapy Trial (OXB‐102/Axo‐Lenti‐PD) in People with Parkinson's Disease to the moderator's attention — for example: off-topic, undisclosed promotion, broken link, scam, or misleading content. For a problem with the site itself — a bug, something broken or confusing, or a suggestion — use Send feedback instead.
The moderator sees the reason you give and your email address. Reports are aggregated — once enough readers report the same item, it goes to the moderator queue, and beyond a higher threshold it is removed automatically.
An HTML render of the page as you saw it will be attached so the moderator can verify what you reported.